EWA
AMPE

EP Wealth Advisors’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

EP Wealth Advisors’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-41
Closed -$6K – 303
2018
Q3 		$6K Hold
41
– – ﹤0.01% 279
2018
Q2 		$27K Buy
+41
New +$30.7K ﹤0.01% 187

Other funds holding AMPE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
CC
Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
MA
Montag & Associates Atlanta, Georgia $2.15B AUM 20.86% 1-Year Est. Return
CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $108M AUM 54.47% 1-Year Est. Return

EP Wealth Advisors's AMPE Position: Q4 2018 in Review

EP Wealth Advisors sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q4 2018, closing a stake of 41 shares — an estimated $6K sold.

EP Wealth Advisors first reported a position in AMPE in Q2 2018 and held it in 2 quarters. The position peaked at $27K in Q2 2018. 89 funds tracked by Wall St. Rank hold AMPE as of Q4 2018.

  • EP Wealth Advisors reported no remaining Ampio Pharmaceuticals Inc. position as of Q4 2018 after selling out during the quarter.
  • EP Wealth Advisors sold 41 Ampio Pharmaceuticals Inc. shares in Q4 2018, an estimated $6K.
  • EP Wealth Advisors first reported a position in Ampio Pharmaceuticals Inc. in Q2 2018 and held it in 2 quarters.
  • EP Wealth Advisors's Ampio Pharmaceuticals Inc. position peaked at $27K in Q2 2018.
  • 89 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2018.

Based on EP Wealth Advisors's 13F filing for Q4 2018, filed 19 Feb 2019.